BCL2 and myeloid leukemia: Consistent with recent studies, the inhibition of the PI3K/AKT pathway significantly induces antiapoptosis and promotes survival through Mcl-1 and Bcl-2 degradation in AML [43], human myeloid leukemia cells [44], and HCC [45].